HER3 and LINC00052 interplay promotes tumor growth in breast cancer

Ahmad Salameh(University of Turin), Zhiqiang An(Brown Foundation)

Oncotarget

December 27, 2016

10.18632/oncotarget.14313

Cited by 32

Related Papers

Antibody-drug conjugates: recent advances in conjugation and linker chemistries

|Protein & Cell|2016|746

Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways

|Blood|2005|174

Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation

|Breast Cancer Research|2014|62